Nepal launched on Wednesday a vaccination drive against the new coronavirus that has killed slightly over 2,000 people so far in the Himalayan nation.In the first phase, nearly 430,000 people, such as health care workers, sanitation workers, security personnel, ambulance operators and prisoners, will be inoculated using 1 million doses recently donated by neighboring India.The vaccine used in the campaign is Covishield -- developed by British drugmaker AstraZeneca Plc and the University of Oxford, and manufactured by Serum Institute of India.Earlier this month, Nepal approved the vaccine fo…READ FULL ARTICLE